JOURNAL CLUB · LANDMARK TRIAL
Delivery-room management of the apparently vigorous meconium-stained neonate
Wiswell TE, Gannon CM, Jacob J, et al. Pediatrics. 2000;105(1):1-7. A multicentre, international randomised controlled trial.
MECONIUM -
DON'T INTUBATE
No reduction in MAS
MAS occurred in 3.2% (suctioned) vs 2.7% (expectant) - routine suctioning did not help.
No difference in other respiratory disease
Other respiratory disorders 3.8% vs 4.5% - no benefit even with the thickest meconium.
Intubation has its own costs
Procedure complications ~3.8% - infrequent and mostly transient, and not related to operator seniority.
Who is at risk of MAS
Risk markers: caesarean, low Apgar, oligohydramnios, abnormal / absent FHR monitoring, thick meconium, few antenatal visits.
WHY THIS MATTERS
- Routine intubation and suctioning of all MSAF infants was standard, based on observational data
- MSAF is common, so the practice affected huge numbers of babies
- Intubation is invasive, needs skill and carries risk
- There was conflicting evidence and no strong RCT for a selective approach
- Getting this right avoids intubating well babies who do not benefit
STRENGTHS
- The largest RCT of delivery-room management of vigorous meconium-stained infants
- Multicentre and international
- Addressed a common, high-stakes practice directly
- Findings were consistent across centres
- A clear, practice-changing message
LIMITATIONS
- Unmasked - caregivers knew the intervention (performance / detection bias)
- 89% of infants came from 6 of the 12 centres (though outcomes were similar)
- Waiver of consent - defensible then, but would face more scrutiny today
- Applies only to VIGOROUS infants - not the non-vigorous, where evidence is limited
- Since then, intubation skills have declined as expectant management spread
Practice implications
Before this trial, every meconium-stained baby - vigorous or not - was routinely intubated and suctioned. Wiswell et al. showed that for the apparently vigorous term infant, routine intubation and tracheal suctioning did not reduce MAS or other respiratory disease, even with thick meconium, and carries procedural risk. This drove the shift to supportive, non-invasive management of vigorous MSAF infants, and underpins the ILCOR (2015) recommendation against routine intubation of MSAF infants. For the non-vigorous infant the evidence is weaker; current practice prioritises effective ventilation over routine tracheal suctioning, but this remains an area of uncertainty. Know your local delivery-room guideline.
How do you define a "vigorous" versus "non-vigorous" meconium-stained baby?
What do you do at the birth of a non-vigorous MSAF infant, and why is the evidence weaker there?
How has the move away from routine intubation affected airway skills, and how do you maintain them?
How do you weigh a waiver-of-consent trial ethically today?
Pediatrics 2000 ANZCOR
Newborn resuscitation MAS
The Hub condition page LANDMARK TRIALS
More trials to know
Take-home message: Wiswell et al. showed that vigorous term infants born through meconium-stained fluid do just as well with expectant management as with routine intubation and tracheal suctioning - MAS was no less common (3.2% vs 2.7%), even with thick meconium - while intubation carries its own risk. It moved practice away from routine intubation toward supportive, non-invasive care of the vigorous meconium-stained baby, and underpins the ILCOR recommendation against routine MSAF intubation. Management of the non-vigorous infant remains less certain.
For educational purposes only. Journal club appraisal - figures paraphrased from the published trial and later reviews; read the full article for complete data. Always align practice to current ANZCOR/NRP guidelines.